(8S,9S,10R,13S,14S)-13-Ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name)(CAS: 54024-21-4)
![(8S,9S,10R,13S,14S)-13-Ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name) (8S,9S,10R,13S,14S)-13-Ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name)](https://cnstatic.chemtradehub.com/structs/540/54024-21-4-ecf3.webp)
CAS号
相关产品
其他供应商提供的 (8S,9S,10R,13S,14S)-13-Ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name)
基本信息
分子式
C20H28O
分子量
284.44 g/mol
Physical Properties
熔点
99-1010C
化学标识符
SMILES
CCC12CC(=C)C3C(C1CCC2=O)CCC4=CCCCC34
InChIKey
KVNYZZFGXXHVMG-CAVMOMJPSA-N
数据库引用
MDL号
MFCD08458336
常见问题
该化合物需遵循《全球化学品统一分类和标签制度》(GHS)的相关分类,包括急性毒性、皮肤刺激和严重眼损伤等类别。在中国,还需符合《危险化学品安全管理条例》的相关要求。在欧洲,需遵守REACH法规,特别是关于物质和混合物的注册、评估、授权和限制。此外,对于食品接触材料和消费品,还需符合FDA和EPA的相关规定。
目前市场上没有完全相同的替代品,但可以考虑使用其他结构相似的化合物作为替代,例如13-甲基-11-亚甲基-4-雌烯-17-酮或13-异丙基-11-亚甲基-4-雌烯-17-酮等。这些化合物在结构上有一定的相似性,可以部分替代13-乙基-11-亚甲基-4-雌烯-17-酮。
该化合物主要应用于药物合成和天然产物研究领域。近年来,随着绿色化学和可持续发展的推动,研究人员倾向于寻找更环保、更安全的合成方法。此外,随着对雌激素类似物研究的深入,该化合物在药物开发中的应用前景值得关注。预计未来几年,该化合物的市场需求将保持稳定增长。
对于含该化合物的废料处理,首先应确保废料收集过程中的安全措施,避免泄漏和污染。对于少量废料,可以采用水溶解后,加入碱性物质中和,然后进行无害化处理。对于大量废料,建议送往专业的废物处理中心进行焚烧或化学处理。在处理过程中,需严格遵守相关环保法规,确保处理过程中的安全性。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序


![(8R,9S,13S,14S)-13-Ethyl-3-methoxy-1,4,6,7,8,9,11,12,13,14,15,16-dodecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name)](https://cnstatic.chemtradehub.com/structs/232/2322-77-2-9bc0.webp)



![(1aR,1bR,3S,5aR,5bS,7aS,8aS,9aS,9bS,9cR,9dR)-1b,3-Dihydroxy-5a,7a-dimethyloctadecahydro-8H-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthren-8-one](https://cnstatic.chemtradehub.com/structs/825/82543-16-6-fbb4.webp)
![(8S,9S,10R,11R,13S,14S,17R)-11-Hydroxy-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione](https://cnstatic.chemtradehub.com/structs/192/192569-17-8-1c97.webp)
![(2'R,7R,8R,10S,13S,14S)-Methyl 10,13-dimethyl-3,5'-dioxo-1,2,3,4',5',6,7,8,10,12,13,14,15,16-tetradecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-carboxylate](https://cnstatic.chemtradehub.com/structs/957/95716-70-4-92a0.webp)

![(8S,9S,10R,13S,14S)-13-Ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name) — 金锦乐(湖南)化学有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce76192b2de6e8e95a464e/67ce76192b2de6e8e95a464e-logo.webp)
![(8S,9S,10R,13S,14S)-13-Ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name) — 赫澎(上海)生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ceccf22b2de6e8e95a5e0f/67ceccf22b2de6e8e95a5e0f-logo.webp)
![(8S,9S,10R,13S,14S)-13-Ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name) — 上海吉至生化科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecbee2b2de6e8e95a5b72/67cecbee2b2de6e8e95a5b72-logo.webp)
![(8S,9S,10R,13S,14S)-13-Ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name) — 湖北扬信医药科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cded3957537e5c8069af88/67cded3957537e5c8069af88-logo.webp)
![(8S,9S,10R,13S,14S)-13-Ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name) — 上海绩祥生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce6f4d2b2de6e8e95a45bf/67ce6f4d2b2de6e8e95a45bf-logo.webp)
![(8S,9S,10R,13S,14S)-13-Ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name) — 上海源叶生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce9f132b2de6e8e95a48fe/67ce9f132b2de6e8e95a48fe-logo.webp)